ROYAL BANK OF CANADA - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
938
-11.8%
0.00%
Q2 2023$1,000
-66.7%
1,063
-65.6%
0.00%
Q1 2023$3,000
-62.5%
3,093
-55.1%
0.00%
Q4 2022$8,000
-50.0%
6,891
+234.2%
0.00%
Q3 2022$16,000
+128.6%
2,062
+83.9%
0.00%
Q2 2022$7,000
-68.2%
1,121
-58.7%
0.00%
Q1 2022$22,000
-40.5%
2,717
-61.7%
0.00%
Q4 2021$37,000
+19.4%
7,085
+51.7%
0.00%
Q3 2021$31,000
+24.0%
4,669
+58.7%
0.00%
Q2 2021$25,000
-13.8%
2,942
-10.2%
0.00%
Q1 2021$29,000
-14.7%
3,276
+16.7%
0.00%
Q4 2020$34,000
+466.7%
2,807
+274.3%
0.00%
Q3 2020$6,000
-14.3%
750
-0.9%
0.00%
Q2 2020$7,000
+40.0%
757
+12.8%
0.00%
Q1 2020$5,000
-86.5%
671
-73.5%
0.00%
Q4 2019$37,000
+825.0%
2,532
+655.8%
0.00%
Q2 2019$4,000335
+2133.3%
0.00%
Q3 2018$015
+1400.0%
0.00%
Q2 2018$0
-100.0%
1
-99.3%
0.00%
Q1 2017$2,000
-50.0%
152
-52.6%
0.00%
Q4 2016$4,0003210.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders